Superficial Femoral Artery Endovascular Therapy with Atherectomy
Peripheral vascular disease is better recognized as an epidemic that’s impacting millions of patients and their families. Health-care providers currently consider PVD as a significant comorbidity and have been actively screening, treating, and spreading public awareness. In addition to medical therapy, surgery has been considered the mainstay of therapy for years. The recent advancement in endovascular technology and the increasing level of expertise by endovascular specialist allow revascularization in patients deemed inoperable in the past. This chapter highlights through our case presentation the current evidence behind endovascular therapy in patients with superficial femoral artery disease. We also discuss some of the current devices available and used by endovascular operators.
KeywordsCatheter Ischemia Perforation
- 5.Forbes JF, Adam DJ, Bell J, Fowkes FG, Gillespie I, Raab GM, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis. J Vasc Surg. 2010;51(5 Suppl):43S–5151.PubMedCrossRefGoogle Scholar
- 8.Krankenberg H, Schluter M, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116(3):285–92.PubMedCrossRefGoogle Scholar
- 9.Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3(3):267–76.PubMedCrossRefGoogle Scholar